MSF Field Research > 1 Published Research and Commentary > TB > The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure.

Please use this identifier to cite or link to this item: http://hdl.handle.net/10144/255350
    Del.icio.us     LinkedIn     Citeulike     Connotea     Facebook     Stumble it!


Download this article:
View/Open File Description Size Format
Thumbnail
View/Open
49. The role of targeted viral load - TM&IH 2012-09-14.pdf54KbAdobe PDF

Title: The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure.
Authors: Davies, Mary-Ann
Boulle, Andrew
Technau, Karl
Eley, Brian
Moultrie, Harry
Rabie, Helena
Garone, Daniela
Giddy, Janet
Wood, Robin
Egger, Matthias
Keiser, Olivia
Affiliation:  School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa  Empilweni Service and Research Unit, Rahima Moosa Mother and Child Hospital and University of Witwatersrand, Johannesburg, South Africa  Red Cross Children's Hospital and School of Child and Adolescent Health, University of Cape Town, Cape Town, South Africa  Wits Reproductive Health and HIV Institute (Harriet Shezi Children's Clinic, Chris Hani Baragwanath Hospital, Soweto), Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa  Tygerberg Academic Hospital, University of Stellenbosch, Stellenbosch, South Africa  Médecins Sans Frontières South Africa and Khayelitsha ART Programme, Khayelitsha, Cape Town, South Africa  Sinikithemba Clinic, McCord Hospital, Durban, South Africa  Gugulethu Community Health Centre and Desmond Tutu HIV Centre, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa  Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Citation: The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure. 2012: Trop. Med. Int. Health
Journal: Tropical Medicine & International Health : TM & IH
Issue Date: 14-Sep-2012
URI: http://hdl.handle.net/10144/255350
DOI: 10.1111/j.1365-3156.2012.03073.x
PubMed ID: 22974345
Additional Links: http://onlinelibrary.wiley.com/doi/10.1111/j.1365-3156.2012.03073.x/abstract;jsessionid=8CEC162F2C518133AA59744BF32FA561.d01t02?systemMessage=Wiley+Online+Library+will+be+disrupted+on+15+December+from+10%3A00-12%3A00+GMT+%2805%3A00-07%3A00+EST%29+for+essential+maintenance
Abstract: Objectives  To determine the improvement in positive predictive value of immunological failure criteria for identifying virological failure in HIV-infected children on antiretroviral therapy (ART) when a single targeted viral load measurement is performed in children identified as having immunological failure. Methods  Analysis of data from children (<16 years at ART initiation) at South African ART sites at which CD4 count/per cent and HIV-RNA monitoring are performed 6-monthly. Immunological failure was defined according to both WHO 2010 and United States Department of Health and Human Services (DHHS) 2008 criteria. Confirmed virological failure was defined as HIV-RNA >5000 copies/ml on two consecutive occasions <365 days apart in a child on ART for ≥18 months. Results  Among 2798 children on ART for ≥18 months [median (IQR) age 50 (21-84) months at ART initiation], the cumulative probability of confirmed virological failure by 42 months on ART was 6.3%. Using targeted viral load after meeting DHHS immunological failure criteria rather than DHHS immunological failure criteria alone increased positive predictive value from 28% to 82%. Targeted viral load improved the positive predictive value of WHO 2010 criteria for identifying confirmed virological failure from 49% to 82%. Conclusion  The addition of a single viral load measurement in children identified as failing immunologically will prevent most switches to second-line treatment in virologically suppressed children.
Type: Article
Language: en
Keywords: HIV/AIDS
ISSN: 1365-3156
Rights: Archived on this site with the kind permission of Wiley-Blackwell, http://www.blackwell-synergy.com/loi/tmi
Appears in topics: TB

Related articles on PubMed
bullet
Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa Collaboration.
Davies MA, Boulle A, Eley B, Moultrie H, Technau K, Rabie H, van Cutsem G, Giddy J, Wood R, Egger M, Keiser O, International epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA‐SA) Collaboration
2011 Nov
bullet
Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.
Orrell C, Harling G, Lawn SD, Kaplan R, McNally M, Bekker LG, Wood R
2007
bullet
Performance of immunological response in predicting virological failure.
Ingole N, Mehta P, Pazare A, Paranjpe S, Sarkate P
2013 Mar
bullet
bullet
Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.
Oliveira R, Krauss M, Essama-Bibi S, Hofer C, Robert Harris D, Tiraboschi A, de Souza R, Marques H, Succi R, Abreu T, Della Negra M, Hazra R, Mofenson LM, Siberry GK, NISDI Pediatric Study Group 2010
2010 Dec 1
See all 147 articles

All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.

 

OR Logo Powered by Open Repository | Cookies

My MSF

MSF logo MSF Field Research

Oct 21, 2014